Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat
Rahaghi, Franck F., Balasubramanian, Vijay P., Bourge, Robert C., Burger, Charles D., Chakinala, Murali M., Eggert, Michael S., Elwing, Jean M., Feldman, Jeremy, King, Christopher, Klinger, James R., Mathai, Stephen C., McConnell, John Wesley, Palevsky, Harold I., Restrepo‐Jaramillo, Ricardo, Safdar, Zeenat, Sager, Jeffrey S., Sood, Namita, Sulica, Roxana, White, R. James, Hill, Nicholas S.
Published in Pulmonary circulation (01.04.2022)
Published in Pulmonary circulation (01.04.2022)
Get full text
Journal Article
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)
Minhas, Jasleen, Narasimmal, Sai Prasanna, M. Bull, Todd, Marco, Teresa De, McConnell, John Wesley, Lammi, Matthew R., Thenappan, Thenappan, P. Feldman, Jeremy, S. Sager, Jeffrey, B. Badesch, David, Ryan, John J., C. Grinnan, Daniel, Zwicke, Dianne, M. Horn, Evelyn, Elwing, Jean M., Moss, John E., Eggert, Michael, Shlobin, Oksana A., P. Frantz, Robert, D. Bartolome, Sonja, Mathai, Stephen C., Mazimba, Sula, C. Pugliese, Steven, Al-Naamani, Nadine
Published in Pulmonary circulation (01.10.2021)
Published in Pulmonary circulation (01.10.2021)
Get full text
Journal Article